Eric Morgen - Sep 25, 2024 Form 3 Insider Report for BioAge Labs, Inc. (BIOA)

Role: Chief Operating Officer, Director
Signature: /s/ Dov A. Goldstein as attorney-in-fact
Stock symbol: BIOA
Transactions as of: Sep 25, 2024
Transactions value $: $0
Form type: 3
Date filed: 9/25/2024, 04:47 PM
Previous filing: Sep 27, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BIOA	Common Stock						67.2K	Sep 25, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	79.4K	$3.08	Direct	F1
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	92.8K	$10.27	Direct	F2
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	42.9K	$6.57	Direct	F3
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	42.9K	$10.85	Direct	F4
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	258K	$8.39	Direct	F5
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	1.23K	$3.89	By Spouse	F6, F7
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	493	$4.11	By Spouse	F7, F8
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	6.27K	$10.27	By Spouse	F7, F9
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	2.46K	$6.57	By Spouse	F7, F10
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	2.46K	$10.85	By Spouse	F7, F11
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	13.6K	$8.39	By Spouse	F7, F12

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 21, 2022.
F2	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on January 16, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F3	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F4	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F5	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.
F6	The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on September 25, 2023.
F7	Represents an employee stock option directly held by the reporting person's spouse.
F8	The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 24, 2024.
F9	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on March 15, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F10	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F11	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F12	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.